Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Covalent Reversible Inhibitors of Cysteine Proteases Containing the Nitrile Warhead: Recent Advancement in the Field of Viral and Parasitic Diseases
Simone Brogi, Roberta Ibba, Sara Rossi, et al.
Molecules (2022) Vol. 27, Iss. 8, pp. 2561-2561
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

SARS-CoV-2 3CL pro mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376
Emmanuel Heilmann, Francesco Costacurta, Seyed Arad Moghadasi, et al.
Science Translational Medicine (2022) Vol. 15, Iss. 678
Open Access | Times Cited: 105
The history, mechanism, and perspectives of nirmatrelvir (PF-07321332): an orally bioavailable main protease inhibitor used in combination with ritonavir to reduce COVID-19-related hospitalizations
Ryan Joyce, Vivian W. Hu, Jun Wang
Medicinal Chemistry Research (2022) Vol. 31, Iss. 10, pp. 1637-1646
Open Access | Times Cited: 93
Alkyne Derivatives of SARS-CoV-2 Main Protease Inhibitors Including Nirmatrelvir Inhibit by Reacting Covalently with the Nucleophilic Cysteine
Lennart Brewitz, Leo Dumjahn, Yilin Zhao, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 4, pp. 2663-2680
Open Access | Times Cited: 47
Nitriles: an attractive approach to the development of covalent inhibitors
Vinícius Bonatto, Rafael F. Lameiro, Fernanda dos Reis Rocho, et al.
RSC Medicinal Chemistry (2022) Vol. 14, Iss. 2, pp. 201-217
Open Access | Times Cited: 40
The pyridazine heterocycle in molecular recognition and drug discovery
Nicholas A. Meanwell
Medicinal Chemistry Research (2023) Vol. 32, Iss. 9, pp. 1853-1921
Open Access | Times Cited: 30
Recent Advances on Targeting Proteases for Antiviral Development
Pedro Henrique Oliveira Borges, Sabrina Baptista Ferreira, Floriano Paes Silva
Viruses (2024) Vol. 16, Iss. 3, pp. 366-366
Open Access | Times Cited: 9
Flavin-Mediated Photocatalysis Provides a General Platform for Sulfide C–H Functionalization
Alex S. Anderton, Oliver J. Knowles, James A. Rossi‐Ashton, et al.
ACS Catalysis (2024) Vol. 14, Iss. 4, pp. 2395-2401
Open Access | Times Cited: 8
Discovery of Nirmatrelvir (PF-07321332): A Potent, Orally Active Inhibitor of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Main Protease
Jamison B. Tuttle, Christophe Allais, Charlotte Allerton, et al.
Journal of Medicinal Chemistry (2025)
Closed Access | Times Cited: 1
Fast Cysteine Bioconjugation Chemistry
Fa‐Jie Chen, Jianmin Gao
Chemistry - A European Journal (2022) Vol. 28, Iss. 66
Open Access | Times Cited: 32
Exploring diverse reactive warheads for the design of SARS-CoV-2 main protease inhibitors
Bin Tan, M. Sacco, Haozhou Tan, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115667-115667
Open Access | Times Cited: 20
Advances in research on 3C-like protease (3CLpro) inhibitors against SARS-CoV-2 since 2020
Roufen Chen, Yali Gao, Han Liu, et al.
RSC Medicinal Chemistry (2022) Vol. 14, Iss. 1, pp. 9-21
Open Access | Times Cited: 25
Biology of the mpox virus and the cysteine protease structures and basis of in silico studies
Samriddhi Ranjan, Tejveer Singh, Kanupriya Vashishth, et al.
Elsevier eBooks (2025), pp. 135-148
Closed Access
Synthesis and biological investigation of peptidomimetic SARS‐CoV‐2 main protease inhibitors bearing quinoline‐based heterocycles at P3
Sara Rossi, Graziano Deidda, Lia Fiaschi, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 1
Closed Access
Development and Application of Reversible and Irreversible Covalent Probes for Human and Mouse Cathepsin‐K Activity Detection, Revealing Nuclear Activity
Gourab Dey, Reut Sinai‐Turyansky, Evalyn Yakobovich, et al.
Advanced Science (2024) Vol. 11, Iss. 38
Open Access | Times Cited: 3
Investigation of the Compatibility between Warheads and Peptidomimetic Sequences of Protease Inhibitors—A Comprehensive Reactivity and Selectivity Study
Patrick Müller, Mergim Meta, J. Laurenz Meidner, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7226-7226
Open Access | Times Cited: 8
Biocompatible Synthesis of Macrocyclic Thiazol(in)e Peptides
Junming He, Christoph Nitsche
Chemistry - A European Journal (2024) Vol. 30, Iss. 38
Open Access | Times Cited: 2
Covalent-reversible peptide-based protease inhibitors. Design, synthesis, and clinical success stories
Anthony Feral, Anthony R. Martin, Alexandre Desfoux, et al.
Amino Acids (2023) Vol. 55, Iss. 12, pp. 1775-1800
Closed Access | Times Cited: 5
Advances in the Search for SARS-CoV-2 Mpro and PLpro Inhibitors
Marcel Arruda Diogo, Augusto Gomes Teixeira Cabral, Renata Barbosa de Oliveira
Pathogens (2024) Vol. 13, Iss. 10, pp. 825-825
Open Access | Times Cited: 1
Local and Sustained Baricitinib Delivery to the Skin through Injectable Hydrogels Containing Reversible Thioimidate Adducts
Leo Wang, Spencer Tuohy, Karen Xu, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 12
Closed Access | Times Cited: 1
Covalent DNA-Encoded Library Workflow Drives Discovery of SARS-CoV-2 Non-structural Proteins Inhibitors
Xiaojie Lu, Hangchen Hu, Lianghe Mei, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Sustainable and Chemoselective Synthesis of α-Aminonitriles Using Lewis and Brønsted Acid-Functionalized Nanoconfined Spaces
Chloe A. Ramsperger, Noah Q. Tufts, Ankit K. Yadav, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 44, pp. 49957-49964
Closed Access | Times Cited: 7
4-Cyanamido-substituted benzenesulfonamides act as dual carbonic anhydrase and cathepsin inhibitors
Morteza Abdoli, Vesa Krasniqi, Alessandro Bonardi, et al.
Bioorganic Chemistry (2023) Vol. 139, pp. 106725-106725
Closed Access | Times Cited: 2
Identification of the interaction between MAPK1 and <italic>Eimeria acervulina</italic>serine protease inhibitor: a preliminary functional study
Liyin Lian, He Sun, Wanjing Li, et al.
Acta Biochimica et Biophysica Sinica (2024)
Open Access
Photoredox/Cu dual catalyzed 1,4-cyanosulfonylation enabled by remote cyano migration
Xiaofei Xie, Xiaobin Li, Zhengyuan Bo, et al.
Organic Chemistry Frontiers (2024) Vol. 11, Iss. 17, pp. 4857-4861
Closed Access
Covalent Inhibitors of MAP Kinases
Surya K. De
Drug design and discovery (2024), pp. 159-189
Closed Access
Page 1 - Next Page

Scroll to top